Byrna’s (NASDAQ:BYRN) Q4 Earnings Results: Revenue In Line With Expectations, Stock Soars
Non-lethal weapons company Byrna (NASDAQ:BYRN) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 78.9% year on year to $27.98 million. Its GAAP profit of $0.41 per share was significantly above analysts’ consensus estimates.